Healthcare -
Biotechnology - NASDAQ - US
$ 14.345
-6.73 %
$ 652 M
Market Cap
-14.06
P/E
CAPR - COST OF REVENUE
Cost of Revenue CAPR - Capricor Therapeutics, Inc.
1.07 M
LAST VALUE
108.58%
2 YEAR CAGR
-38.42%
5 YEAR CAGR
-14.63%
10 YEAR CAGR